STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline

Autor: Marty Chaplin, Jamie J. Kirkham, Kerry Dwan, Derek J. Sloan, Geraint Davies, Andrea L. Jorgensen, Irma Aguilar-Delfín, José A G Agúndez, Sophie M Argon, M J Arranz, Derrick A Bennett, Stefan Böhringer, Lawrence Brody, Ingolf Cascorbi, Erika Cecchin, Mandy Crommentuijn-van Rhenen, Ann K Daly, Nur Aizati Athirah Daud, Jorge Duconge, Chiara Fabbri, Alison Fitches, Andrea Gaedigk, Donato Gemmati, Claudia Maria Dan Hawcutt, Rachel Huddart, Evelyne Jacqz-Aigrain, Slobodan M Janković, Theodora Katsila, Gideon Koren, Beata S Lipska-Ziętkiewicz, Thomas Liehr, A H Maitland-van der Zee, Lisanne E N Manson, Martin H Maurer, Juan Eduardo Megías-Vericat, Taichi Ochi, Daniel J O'Connor, Laura B Ramsey, Gad Rennert, Francesco Rucci, Gaetano Santulli, Aris Saoulidis, Rashmi R Shah, Alessandro Serretti, Andrew Somogyi, Gere Sunder-Plassmann, Virginia Boso-Ribelles, Caroline F Thorn, Evangelia Eirini Tsermpini, Satyanarayana Chakradhara Rao Uppugunduri, Michael A van Es, Magdalena Zarowiecki

Publikováno v: PLoS Medicine
PLOS MEDICINE
Chaplin, M, Kirkham, J, Dwan, K, Sloan, D J, Davies, G & Jorgensen, A L 2020, ' STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline ', PL o S Medicine, vol. 17, no. 9, e1003344 . https://doi.org/10.1371/journal.pmed.1003344
PLoS Medicine, Vol 17, Iss 9, p e1003344 (2020)

Background Large sample sizes are often required to detect statistically significant associations between pharmacogenetic markers and treatment response. Meta-analysis may be performed to synthesize data from several studies, increasing sample size a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0723340d500283390e03c6511decabd3
https://doi.org/10.1371/journal.pmed.1003344